 Connection
Matthew Daley to Antihypertensive Agents
This is a "connection" page, showing publications Matthew Daley has written about Antihypertensive Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.076 |
|
|
|
-
Daley MF, Rifas-Shiman SL, Young JG, Petimar J, Prentice C, Bailey LC, Janicke DM, Heerman WJ, Block JP. Effects of Common Antihypertensive Class Medications on BMI z-Score in Adolescents. Pediatr Obes. 2026 May; 21(5):e70114.
Score: 0.714
-
Lin PD, Rifas-Shiman SL, Petimar J, Yu H, Daley MF, Janicke DM, Heerman WJ, Bailey LC, Maeztu C, Lewis KH, Young JG, Block JP. Emulation of a Target Trial of Antihypertensive Medications on Weight Change. J Gen Intern Med. 2026 03; 41(4):1097-1106.
Score: 0.172
-
Lin PD, Rifas-Shiman S, Merriman J, Petimar J, Yu H, Daley MF, Janicke DM, Heerman WJ, Bailey LC, Maeztu C, Young J, Block JP. Trends of Antihypertensive Prescription Among US Adults From 2010 to 2019 and Changes Following Treatment Guidelines: Analysis of Multicenter Electronic Health Records. J Am Heart Assoc. 2024 05 07; 13(9):e032197.
Score: 0.155
-
Rifas-Shiman SL, Aris IM, Bailey C, Daley MF, Heerman WJ, Janicke DM, Lin PD, Petimar J, Block JP. Changes in obesity and BMI among children and adolescents with selected chronic conditions during the COVID-19 pandemic. Obesity (Silver Spring). 2022 10; 30(10):1932-1937.
Score: 0.035
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|